Both selective cox-2 inhibitors and non-selective nsaids increase the risk of acute myocardial infarction in patients with arthritis: Selectivity is with the patient, not the drug class

被引：0
|
作者：
Singh, G
Mithal, A
Triadafilopoulos, G
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Inst Clin Outcomes Res & Educ, Palo Alto, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：85 / +
页数：2
相关论文
共 50 条
  • [21] The relationship between selective COX-2 inhibitors and acute myocardial infarction.
    Solomon, DH
    Schneeweiss, S
    Glynn, RJ
    Kiyota, Y
    Cannuscio, CC
    Levin, R
    Mogun, H
    Avom, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S697 - S697
  • [22] Use of first- and second-generation COX-2 selective NSAIDS and the Risk of Acute Myocardial Infarction
    Andersohn, F
    Suissa, S
    Garbe, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 701 - 701
  • [23] Tolerance of selective inhibitors of COX-2 in patients allergics to NSAIDS
    Chamorro, C.
    Ventura, I
    Aroca, R.
    Vega, A.
    Guardia, P.
    de, Luque, V
    Conde, J.
    Monteseirin, J.
    ALLERGY, 2008, 63 : 204 - 204
  • [24] Tolerability of selective COX-2 inhibitors in patients with hypersensitivity to NSAIDs
    Pagani, M.
    Bonadonna, P.
    Senna, G.
    Antico, A.
    Passalacqua, G.
    ALLERGY, 2008, 63 : 588 - 588
  • [25] The effects of COX-2 selective and non-selective NSAIDs on the initiation and progression of atherosclerosis in ApoE−/− mice
    Julia Metzner
    Laura Popp
    Claudiu Marian
    Ronald Schmidt
    Christine Manderscheid
    Christoph Renne
    Beate Fisslthaler
    Ingrid Fleming
    Rudi Busse
    Gerd Geisslinger
    Ellen Niederberger
    Journal of Molecular Medicine, 2007, 85 : 623 - 633
  • [26] Adverse lower gastrointestinal effects of non-selective and COX-2 selective NSAIDs: A systematic review
    Laine, Loren
    Smith, Rebecca A.
    Min, Kejia
    Chen, Connie
    Dubois, Robert W.
    GASTROENTEROLOGY, 2006, 130 (04) : A303 - A304
  • [27] Risks and benefits of COX-2 inhibitors versus non-selective NSAIDs: Does their cardiovascular risk exceed their gastrointestinal benefit?
    Rahme, Elham
    Nedjar, Hacene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S61 - S61
  • [28] Evaluating cardiovascular and gastrointestinal risks and benefits of COX-2 selective inhibitors and non-selective nsaids in osteoarthritis patients using a decision analytic model
    Mittmann, N.
    Risebrough, N.
    Choy, E.
    Knowles, S.
    Chen, C.
    Lising, A.
    Almeida, T.
    Koncz, T.
    Niculescu, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 504 - 504
  • [29] Co-Prescription of Gastroprotective Agents in Patients Taking Non-Selective NSAIDs or COX-2 Selective Inhibitors: A Hospital Based Retrospective Study
    Thobari, Jarir A. T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 415 - 415
  • [30] The effects of COX-2 selective and non-selective NSAIDs on the initiation and progression of atherosclerosis in ApoE-/- mice
    Metzner, Julia
    Popp, Laura
    Marian, Claudiu
    Schmidt, Ronald
    Manderscheid, Christine
    Renne, Christoph
    Fisslthaler, Beate
    Fleming, Ingrid
    Busse, Rudi
    Geisslinger, Gerd
    Niederberger, Ellen
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2007, 85 (06): : 623 - 633
12345